(Reuters) - The Food and Drug Administration has for the third time refused approval to Endo Health Solutions Inc's injectable testosterone drug Aveed, pressing for a still better plan to manage the risks associated with the drug.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/EkVpz2hXqMI/story01.htm
get phlebotomy certification how to get phlebotomy certification phlebotomists courses
No comments:
Post a Comment